Terms: = Liver cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
20 results:
1. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
Xiong B; Fu B; Wu Y; Gao F; Hou C
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
[TBL] [Abstract] [Full Text] [Related]
2. eif4a1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
Steinmann SM; Sánchez-Martín A; Tanzer E; Cigliano A; Pes GM; Simile MM; Desaubry L; Marin JJG; Evert M; Calvisi DF
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768380
[TBL] [Abstract] [Full Text] [Related]
3. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
[TBL] [Abstract] [Full Text] [Related]
5. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract] [Full Text] [Related]
6. Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.
Crane CH; Koay EJ
Cancer; 2016 Jul; 122(13):1974-86. PubMed ID: 26950735
[TBL] [Abstract] [Full Text] [Related]
7. prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.
Dang HZ; Yu Y; Jiao SC
World J Gastroenterol; 2012 May; 18(19):2402-7. PubMed ID: 22654433
[TBL] [Abstract] [Full Text] [Related]
8. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
[TBL] [Abstract] [Full Text] [Related]
9. Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
Page RD; Romaguera JE; Osborne B; Medeiros LJ; Rodriguez J; North L; Sanz-Rodriguez C; Cabanillas F
Cancer; 2001 Oct; 92(8):2023-9. PubMed ID: 11596015
[TBL] [Abstract] [Full Text] [Related]
10. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract] [Full Text] [Related]
11. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence.
Kayahara M; Nagakawa T; Ohta T; Kitagawa H; Miyazaki I
Surgery; 1997 Jun; 121(6):611-7. PubMed ID: 9186460
[TBL] [Abstract] [Full Text] [Related]
12. Anorectal melanoma: clinical characteristics and the role of abdominoperineal resection.
Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):85-8. PubMed ID: 1642415
[TBL] [Abstract] [Full Text] [Related]
13. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic implications of the localization of carcinoma in the head of the pancreas.
Nix GA; Dubbelman C; Srivastava ED; Wilson JH; Boender J; de Jongh FE
Am J Gastroenterol; 1991 Aug; 86(8):1027-32. PubMed ID: 1858739
[TBL] [Abstract] [Full Text] [Related]
15. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients.
Slingluff CL; Vollmer RT; Seigler HF
Surgery; 1990 Jan; 107(1):1-9. PubMed ID: 2296748
[TBL] [Abstract] [Full Text] [Related]
16. Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Keating MJ; Kantarjian H; Smith TL; Estey E; Walters R; Andersson B; Beran M; McCredie KB; Freireich EJ
J Clin Oncol; 1989 Aug; 7(8):1071-80. PubMed ID: 2666590
[TBL] [Abstract] [Full Text] [Related]
17. A comparison of cancer survival by time period of diagnosis in Hawaii, 1960-1974.
Hinds MW; Nomura AM; Kolonel LN; Lee J
Cancer; 1983 Jan; 51(1):175-8. PubMed ID: 6821802
[TBL] [Abstract] [Full Text] [Related]
18. [Diagnosis, treatment and prognosis of malignant tumors of the liver and extrahepatic bile ducts in the last 20 years].
Grundmann R; Leichenich A
Chirurg; 1982 Sep; 53(9):563-70. PubMed ID: 6184203
[TBL] [Abstract] [Full Text] [Related]
19. cancer of the breast. Staging methods, primary treatment options and end results.
Donegan WL
Major Probl Clin Surg; 1979; 5():221-301. PubMed ID: 379450
[TBL] [Abstract] [Full Text] [Related]
20. [Malignant epithelial liver tumours in children (author's transl)].
Gutjahr P; Höhn P; Wagner R
Dtsch Med Wochenschr; 1975 Mar; 100(12):584-9. PubMed ID: 164333
[TBL] [Abstract] [Full Text] [Related]
